(Q46726525)

24 December 2017

title

Usefulness of hepatocytes for evaluating the genetic polymorphism of CYP2D6 substrates (English)

1 reference

24 December 2017

author name string

Komura H

series ordinal

1

1 reference

24 December 2017

Iwaki M

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

24 December 2017

published in

Xenobiotica

1 reference

24 December 2017

volume

35

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

575-587

1 reference

24 December 2017

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Formation of a quaternary N-glucuronide of amitriptyline in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: the female DA rat is not always an animal model for poor metabolizers of CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Nonlinear pharmacokinetics of propafenone in rats and humans: application of a substrate depletion assay using hepatocytes for assessment of nonlinearity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Substrate SARs in human P450s

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expressi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500202056

10.1080/00498250500202056

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017